Celastrol Induces Apoptosis in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells via Caspases-Dependent Pathways and Hsp90 Client Protein Degradation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Celastrol Induces Apoptosis in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells via Caspases-Dependent Pathways and Hsp90 Client Protein Degradation
Authors
Keywords
-
Journal
MOLECULES
Volume 19, Issue 3, Pages 3508-3522
Publisher
MDPI AG
Online
2014-03-22
DOI
10.3390/molecules19033508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
- (2013) Makoto Sudo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer
- (2013) Zi Liu et al. CARCINOGENESIS
- The Oncogenic Lung Cancer Fusion Kinase CD74-ROS Activates a Novel Invasiveness Pathway through E-Syt1 Phosphorylation
- (2012) H. J. Jun et al. CANCER RESEARCH
- Schizandrin Protects Primary Rat Cortical Cell Cultures from Glutamate-Induced Apoptosis by Inhibiting Activation of the MAPK Family and the Mitochondria Dependent Pathway
- (2012) Meng-Shiou Lee et al. MOLECULES
- Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells
- (2011) Guozhu Chen et al. BMC CANCER
- Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma
- (2011) Ke Gong et al. FREE RADICAL BIOLOGY AND MEDICINE
- FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR
- (2011) Trever G. Bivona et al. NATURE
- Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy
- (2011) Jen-Yi Lee et al. PLoS One
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Olaquindox induces apoptosis through the mitochondrial pathway in HepG2 cells
- (2011) Jiajie Zou et al. TOXICOLOGY
- Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways
- (2011) Haibo Mou et al. TOXICOLOGY IN VITRO
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway
- (2010) X. Pang et al. CANCER RESEARCH
- Celastrol, a Triterpene, Enhances TRAIL-induced Apoptosis through the Down-regulation of Cell Survival Proteins and Up-regulation of Death Receptors
- (2010) Bokyung Sung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
- (2010) Alex Chang LUNG CANCER
- The involvement of mitochondria and the caspase-9 activation pathway in rituximab-induced apoptosis in FL cells
- (2009) Jonna Eeva et al. APOPTOSIS
- The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma
- (2009) Di He et al. BMC CANCER
- TheEML4-ALKfusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-typeEGFRandKRAS
- (2009) Daisy Wing-Sze Wong et al. CANCER
- Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors
- (2009) Yun Jung Choi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential
- (2009) Yanyan Li et al. DRUG RESISTANCE UPDATES
- Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model
- (2009) Dae Yong Kim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Src Promotes Survival and Invasion of Lung Cancers with Epidermal Growth Factor Receptor Abnormalities and Is a Potential Candidate for Molecular-Targeted Therapy
- (2009) E. L.-H. Leung et al. MOLECULAR CANCER RESEARCH
- Double EGFR mutants containing rare EGFR mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations
- (2009) I. Y.-S. Tam et al. MOLECULAR CANCER THERAPEUTICS
- Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression
- (2008) Yulun Huang et al. CANCER LETTERS
- Inhibition of Hsp90 Down-regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel
- (2008) A. Sawai et al. CANCER RESEARCH
- Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells
- (2008) Xin Mao et al. CELL RESEARCH
- EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
- (2008) J. P. Koivunen et al. CLINICAL CANCER RESEARCH
- Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells
- (2008) H.-P. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Signaling networks assembled by oncogenic EGFR and c-Met
- (2008) A. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started